[ET Net News Agency, 19 April 2017] CSPC Pharmaceutical (01093) said it is considering
a possible spin-off and separate listing of CSPC XNW Pharmaceutical Joint Stock Company
Limited and its subsidiaries on a stock exchange in the People's Republic of China.
CSPC XNW is an indirect non-wholly-owned subsidiary of CSPC Pharmaceutical and currently
mainly engages in the manufacture and sales of caffeine (food additives and bulk drugs)
and vitamin C health supplement and beverage products.
On 17 April, the financial advisor of CSPC XNW received a written acknowledgement from
the Hebei Regulatory Bureau of China Securities Regulatory Commission that the application
for pre-listing tutoring process in connection with the proposed spin-off and listing has
been filed and registered. CSPC Pharmaceutical said it will submit an application in
relation to the proposed spin-off and listing to the Hong Kong Stock Exchange for approval
in due course. (HL)
|
|
|
|
|
|
|
|
|
|
IPO News
19/04/2017 08:32
CSPC Pharma (01093) may spin off CSPC XNW on PRC bourse